Colorectal Cancer Trial, Recruiting NCT07255729 Sponsor: City of Hope Medical Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07255729
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with colon cancer (any stage from I to IV) confirmed through laboratory testing of tissue samples
  • People who have had surgery aimed at fully removing the cancer, with or without additional treatments before or after the operation
  • People who have blood samples (plasma or serum) that were collected before surgery and are still available for testing
  • People for whom medical records including clinical details and outcome information are available

Who may not be able to join:

  • People who have not provided written consent to participate in research
  • People whose pre-surgery blood samples are missing or unavailable
  • People for whom survival or cancer recurrence information is not on record
  • People whose records appear more than once in the dataset (duplicate cases)
  • People whose cancer is not the most common type of colon cancer known as adenocarcinoma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ajay Goel, PhD, City of Hope Medical Center

Phone: 626-218-3452

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2025
Est. completion
18 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pathological Stage IIB or higher patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov